-
Exome sequencing
Study
EGAS00001005761
-
Small variants in mtDNA Canary Islands - WGS Oxford Nanopore Technologies (ITER)
Study
EGAS00001005677
-
Molecular landscape of blastic plasmacytoid dendritic cell neoplasm
Study
EGAS00001006166
-
Targeted de-methylation of the FOXP3-TSDR
Study
EGAS00001004867
-
Proteogenomics of chronic lymphocytic leukemia
Study
EGAS00001005746
-
Heat selection enables highly scalable methylome profiling in cell-free DNA for noninvasive monitoring of cancer patients
Study
EGAS00001006198
-
Identification of the dismal subtype of B-ALL with dysregulation of CDX2 and UBTF
Study
EGAS00001005863
-
Defining structural variation associated with breast cancer susceptibility by long-read genome sequencing
Study
EGAS00001005872
-
Extensive patient-to-patient single nuclei transcriptome heterogeneity in pheochromocytomas and paragangliomas
Study
EGAS00001006230
-
The European MAPPYACTS trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies
Study
EGAS00001005935
-
The Proteogenomic Subtypes of Acute Myeloid Leukemia
Study
EGAS00001005950
-
An Isogenic Cell Line Panel for Sequence-based Screening of Targeted Anti-cancer Drugs
Study
EGAS00001005974
-
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs drug target discovery in ankylosing spondylitis
Study
EGAS00001006233
-
Single cell genomic variation induced by mutational processes in cancer
Study
EGAS00001006343
-
Human genome-wide variations in the Massim region
Study
EGAS00001006010
-
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence (ChIP-seq)
Study
EGAS00001006017
-
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
Study
EGAS00001006118
-
Genetic immune escape landscape in primary and metastatic cancer
Study
EGAS00001006123
-
Genetic regulation of gene expression in human brain cell types
Study
EGAS00001006345
-
Loss of Epigenetic Barrier is Required for Enhancer Hijacking-Mediated Oncogenic Transcription
Study
EGAS00001006140
-
DNA methylation-based prognostic subtypes of chordoma tumors in tissue
Study
EGAS00001006406
-
Single cell multi-omic data of glioblastoma evolution under therapy
Study
EGAS00001004909
-
Mapping genetic effects on cell type-specific chromatin accessibility using single nucleus ATAC-seq
Study
EGAS00001006184
-
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
Study
EGAS00001006422
-
Prostate cancer ancestral genomic disparity
Study
EGAS00001006425